Needle-Exchange Plan Curbed HIV Spread.

The findings were published online Sept. 3 in the journal Behavior and Helps. ‘Our study adds to the evidence that needle-exchange programs not only function, but are cost-effective investments in the battle against HIV,’ Monica Ruiz, of George Washington University in Washington, D.C., stated in a university information release. Ruiz can be an assistant study professor in the section of prevention and community wellness at the university’s Milken Institute College of Public Health.Milmont, Ph.D., Yifei Shi, M.S., Ngozi Erondu, M.D., Ph.D., Paul Klekotka, M.D., Ph.D., Brian Kotzin, M.D., and Ajay Nirula, M.D., Ph.D.: Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Psoriasis is an inflammatory pores and skin disease occurring in 2 to 3 percent of the worldwide inhabitants.1,2 Regardless of the availability of several therapies, many patients remain untreated, don’t have an adequate response, or have treatment-related toxic results.3 Interleukin-17 cytokines have already been implicated in the pathogenesis of psoriasis.6,7 Amounts of type 17 helper T cells are increased in psoriatic lesions and so are stimulated by interleukin-23 to release interleukin-17 cytokines.8 Interleukin-17 cytokines, such as interleukin-17A, interleukin-17C, interleukin-17F, and interleukin-17A/F, can induce expression of psoriasis-related proinflammatory molecules in keratinocytes.